About GeneGuide

About company

GeneGuide is a Swiss company dedicated to the identification of novel drug targets and compounds for the treatment of neuropsychiatric disorders. They achieve this goal by combining their proprietary Genome-Based Drug Discovery technology with large-scale human behavioral, genetic and neuroimaging data. Promising drug candidates are tested in proof-of-concept (PoC) clinical trials.